Drug Profile


Alternative Names: AE-IG; Genetic vaccine - Antigen Express

Latest Information Update: 26 Apr 2016

Price : $50

At a glance

  • Originator Antigen Express
  • Class DNA vaccines; Small interfering RNA
  • Mechanism of Action Helper-inducer T-lymphocyte stimulants; Invariant chain inhibitors; RNA interference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Inborn genetic disorders

Most Recent Events

  • 26 Apr 2016 Phase I development is ongoing in USA
  • 03 Dec 2012 Phase-I clinical trials in Inborn genetic disorders in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top